Kolexia
Andre Nicolas Pédiatrie
Andre Nicolas
Pédiatrie
Hôpital La Timone Enfants
Marseille, France
321 Activités
1.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Tumeurs du cerveau Médulloblastome Neuroblastome Mésothéliome Récidive tumorale locale Tumeurs du poumon Gliome infiltrant du tronc cérébral COVID-19

Collaborateurs

Voir plus
Leblond Pierre
Leblond Pierre
Centre Léon-Bérard, Lyon, France
Aerts Isabelle
Aerts Isabelle
Clcc Institut Curie, Paris, France
Verschuur Arnauld
Verschuur Arnauld
Hôpital La Timone Enfants, Marseille, France
Padovani Laetitia
Padovani Laetitia
Hôpital La Timone, Marseille, France

Industries

Voir plus
Accord Healthcare
4 collaboration(s)
Dernière en 2022
All Global
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors: Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors
Essai Clinique (Emd Serono)   08 mars 2024
BIOMEDE 2: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Essai Clinique (Chimerix)   29 février 2024
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: A Phase 1, Multi-center, Open-label, Dose De-escalation Study to Evaluate the Safety and Efficacy of Talimogene Laherparepvec in Pediatric Subjects With Advanced Non Central Nervous System Tumors That Are Amenable to Direct Injection
Essai Clinique (Amgen)   15 février 2024
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
PLGG - MEKTRIC: A Randomized and Controlled Phase II Protocol in Non NF1 Pediatric and AYA (Adolescent and Young Adults) Patients Bearing a Newly Diagnosed Low Grade Glioma With Wild Type BRAF Gene Comparing a Daily Oral MEK Inhibitor (Trametinib) Versus Weekly Vinblastine for 18 Months
Essai Clinique (CHU Strasbourg)   15 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MEMMAT: A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma, Ependymoma and ATRT
Essai Clinique (Medical University of Vienna)   27 janvier 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
European journal of cancer (Oxford, England : 1990)   06 janvier 2024
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial.
Clinical cancer research : an official journal of the American Association for Cancer Research   05 décembre 2023
A new generation of comprehensive precision oncology trials.
The Lancet. Oncology   04 décembre 2023